Over 90 years ago, Hans Selye challenged the notion that stress is inherently negative. He argued that stress is a natural ...

Avecho shares today entered trading halt, pending the release of results for the company's synthetic cannabinoid phase III ...

Canopy Growth (NASDAQ:CGC) operates in the Nasdaq Composite cannabis sector with diversified products including beverages, ...

Digital healthcare has reshaped how patients access physicians, manage chronic conditions, and make decisions about their ...

Because melatonin is sold as a dietary supplement rather than a drug in the US, there is little to no quality control over ...

Cannabidiol (CBD) is a naturally occurring compound found in cannabis, thought to have beneficial effects on things like ...

UK-based Ananda Pharma has announced successful completion of its Phase 1 pharmacokinetic study of its MRX1 cannabidiol oral solution to treat chronic pain conditions, with all study objectives met.

Ananda Pharma Limited is a UK pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions.

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

Hometown Hero, the veteran-supporting cannabusiness of hemp-derived THC and cannabidiol-based products, today announced it will exhibit its portfolio of hemp-derived beverages at ...